Sunesis Pharmaceuticals to Present at the Cowen and Company 36th Annual Health Care Conference
March 09 2016 - 7:46PM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Daniel Swisher, Chief Executive Officer of Sunesis, will present at
the Cowen and Company 36th Annual Health Care Conference on
Tuesday, March 8th at 8:00 AM Eastern Time at The Boston Marriott
Copley Place in Boston, MA.
A live webcast of the presentation will be
available on the Sunesis website at http://ir.sunesis.com. A replay
of the webcast will be archived on the "Calendar of Events" page in
the Investors and Media section of the Sunesis website for two
weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company focused
on the development and commercialization of new oncology
therapeutics for the potential treatment of solid and hematologic
cancers. Sunesis has built a highly experienced cancer drug
development organization committed to improving the lives of people
with cancer and is currently pursuing regulatory approval
in Europe for its lead product candidate, vosaroxin, for
the treatment of relapsed or refractory acute myeloid leukemia in
patients aged 60 and older. In addition, the company is advancing
its kinase-inhibitor pipeline of novel targeted therapies into the
clinic.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024